Asma A. Mokashi

Asma A. Mokashi

Auto-generated profile, based on publicly available information

Asma A. Mokashi

Suryadatta Education Foundation's Suryadatta College of Pharmacy, HealthCare & Research (SCPHR), Survey No. 342, Bavdhan, Pune 411021, Maharashtra, India

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Current Bioactive Compounds
Verified
Journal Article
Closed access
PDF file
AMAsma A. Mokashi
Asma A. Mokashi
NBNeela Bhatia
Neela Bhatia
Background: In addition to being one of the deadliest tumors, breast cancer is also one of the most difficult to cure. Due to the serious side effects of current breast cancer treatments and the rise in drug resistance, current drugs are losing their effectiveness. Potential Natural Bioactives: Bioactive natural compounds target various pathophysiological pathways involved in the development and progression of cancer and hence have the ability to prevent both the growth of breast cancer and the advancement of metastatic disease concurrently. : Natural anticancer compounds have been shown to be effective, complementary treatment may be of great assistance in this case. Clinical Outcomes: Nutraceuticals and popular folk remedies may provide benefits over manufactured pharmaceuticals since they have fewer side effects and less toxicity in both in vitro and in vivo studies. A variety of natural compounds have been shown to reduce the aggressiveness of breast cancer, inhibit the growth of malignant cells, and alter the pathways involved in cancer development and progression. Either by directly affecting certain biological targets, such genes, or by indirectly stabilising conjugates that have an impact on metabolic processes, natural compounds called phytochemicals can enhance human health. Mechanistic Pathways: There are many promising bioactive natural products that can be used to treat breast cancer, including those that inhibit aromatase activity, target HIF-1 signaling, inhibit cytoplasmic signaling, modulate epigenetic regulation, modulate estrogen signaling pathways, or work in chemosensitivity/adjuvant therapy (such as resveratrol, epigallocatechin-3-gallate, and eugenol).

2 July 2024 in Comprehensive Health and Biomedical Studies
Verified
Journal Article
Open access
PDF file
AMAsma Mokashi
Asma Mokashi
NBNeela Bhatia
Neela Bhatia
DPDilnawaz Pathan
Dilnawaz Pathan
HJHemant Jain
Hemant Jain
Background: Breast cancer is a significant global concern, with its burden increasing worldwide. Projections for the coming decades indicate that a substantial proportion of the disease's incidence and mortality will affect underprivileged groups. There is enormous potential in natural products for developing therapeutic agents for breast cancer prevention and treatment. However, research evidence is essential to establish the effectiveness of these organic remedies. Objectives: Using a network ethnopharmacological framework, this study aims to assess the anti-breast cancer effects of Vitis vinifera (grapes), traditionally believed to have anticancer properties. Methods: The study utilized polypharmacological screening to gather information about Vitis vinifera (grapes) from multiple databases. It investigated the relationship between specific bioactives found in Vitis vinifera and targets associated with breast cancer using Binding DB. Results: The network analysis revealed ten potential bioactives interacting with 17 targets related to breast cancer. Among these, quercetin and kaempferol showed a higher number of interactions with the identified targets in the study. Conclusions: The research conducted an in-silico investigation of the cellular mechanisms by which specific bioactive phytoconstituents from Vitis Vinifera influence the inhibition of several targets involved in breast cancer.